• Results
  • Key finding: Access strategies: Less than half of key products are covered by...
Key finding: Access strategies

Less than half of key products are covered by pharma companies’ access strategies in poorer countries

Access strategies with the biggest potential impact on access to medicine are strategies that aim to make products affordable for all patients across the income pyramid. The 2021 Index finds that many of the world’s poor countries still do not benefit significantly from pharma companies' access strategies.

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Back to top |